Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2017 May 16;12(5):e0178015. doi: 10.1371/journal.pone.0178015

Correction: A Novel Quantitative Hemolytic Assay Coupled with Restriction Fragment Length Polymorphisms Analysis Enabled Early Diagnosis of Atypical Hemolytic Uremic Syndrome and Identified Unique Predisposing Mutations in Japan

Yoko Yoshida, Toshiyuki Miyata, Masanori Matsumoto, Hiroko Shirotani-Ikejima, Yumiko Uchida, Yoshifumi Ohyama, Tetsuro Kokubo, Yoshihiro Fujimura
PMCID: PMC5433766  PMID: 28520790

There are two errors in the “Hemolytic assay using citrated human plasma and sheep RBCs” section of the Materials and Methods. The fourth sentence of the second paragraph should read: After incubation, the reaction was quenched by the addition of 1 ml of VBS-EDTA buffer (2.5 mM barbital, 1.5 mM sodium barbital and 144 mM NaCl, and 2 mM EDTA, pH 7.4).

The sixth sentence of the second paragraph should read: Plasma, diluted with AP-CFTD buffer containing 50 mM EDTA was treated in the same manner and used as a blank.

Reference

  • 1.Yoshida Y, Miyata T, Matsumoto M, Shirotani-Ikejima H, Uchida Y, Ohyama Y, et al. (2015) A Novel Quantitative Hemolytic Assay Coupled with Restriction Fragment Length Polymorphisms Analysis Enabled Early Diagnosis of Atypical Hemolytic Uremic Syndrome and Identified Unique Predisposing Mutations in Japan. PLoS ONE 10(5): e0124655 doi:10.1371/journal.pone.0124655 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES